Publications by authors named "Reinhard Dummer"

Claim this Profile
X
X-Ray Therapy of Skin Cancer at Critical Facial Sites: Results of a Tertiary Referral Center.
Sophie Tschopp, Amélie Ciernik, Reinhard Dummer, Laurence Imhof

Dermatology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.
Takami Sato, Marcus O Butler, Sophie Piperno-Neumann, Jessica C Hassel, Paul Nathan, Reinhard Dummer

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial.
Georgina V Long, Charlie Garnett-Benson, Sonia Dolfi, Paolo A Ascierto, Jun Guo, Reinhard Dummer

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanoma.
Egle Ramelyte, Julian Kött, Aleigha R Lawless, Amélie Ciernik, Isabel Heidrich, Reinhard Dummer

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer - results from the Tumor Profiler Melanoma project.
Tarun Mehra, Dominik Menges, Benedict Gosztonyi, Nicola Miglino, Alexander Ring, Reinhard Dummer

NPJ Precis Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the tumor cell-intrinsic ITGB2 axis inhibits melanoma progression.
Erik Rasbach, Laure Migayron, Anne Brandenburg, Praveen Singh, Christina Martins, Reinhard Dummer

Mol Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.
Katharina Schumann, Kai Christian Klespe, Cornelia Mauch, Carmen Loquai, Ulrike Schultheis, Reinhard Dummer

J Eur Acad Dermatol Venereol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastases in the area of the skin graft donor site and partial response following anti-PD1 therapy: A case report.
Marina Schneider, Reinhard Dummer

J Dtsch Dermatol Ges· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant Melanoma.
Flavia L Tellenbach, Luzia Seiler, Mark Johnson, Hubert Rehrauer, Prachi Schukla, Reinhard Dummer

Pigment Cell Melanoma Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International real-world study of combination immunotherapy sequences in metastatic melanoma.
Mora Guardamagna, Sarah E Lochrin, James William Smithy, Michael Postow, Caroline Gaudy-Marqueste, Reinhard Dummer

J Immunother Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.
Julia J Scarisbrick, Pietro Quaglino, Sean Whittaker, Martine Bagot, Emmanuella Guenova, Reinhard Dummer

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pruritus Is an Indicator for Quality of Life in Cutaneous T-Cell Lymphoma.
Andrea Roggo, Yves Wüest, Reinhard Dummer, Egle Ramelyte

J Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Escalation and de-escalation of therapy for high-risk melanomas].
Reinhard Dummer, Lara Valeska Maul, Egle Ramelyte, Joanna Mangana

Ther Umsch· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The Spitz nevus is not a melanoma in childhood].
Mario Teufer, Reinhard Dummer

Ther Umsch· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Reinhard Dummer

Ther Umsch· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate in mycosis fungoides revisited.
Reinhard Dummer, Ariane Suter

J Eur Acad Dermatol Venereol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma.
Nicola Miglino, Nora C Toussaint, Alexander Ring, Ximena Bonilla, Marina Tusup, Reinhard Dummer

Nat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individuals.
Yasser Morsy, Barbara Hubeli, Patrick Turko, Marjam Barysch, Julia M Martínez-Gómez, Reinhard Dummer

Cell Rep Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of multiomics tumor profiling for guiding treatment of melanoma.
Nicola Miglino, Nora C Toussaint, Alexander Ring, Ximena Bonilla, Marina Tusup, Reinhard Dummer

Nat Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective multicenter analysis of real-life toxicity and outcome of ipilimumab and nivolumab in metastatic uveal melanoma.
Amélie Ciernik, Laure Ciernik, Peter Bonczkowitz, Monika Morak, Lucie Heinzerling, Reinhard Dummer

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.
Johanna Mangana, Berna C Özdemir, Daniela Mihic-Probst, Marco Siano, Yannis Metaxas, Reinhard Dummer

Swiss Med Wkly· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of Suspension and Imaging Mass Cytometry Single-Cell Readouts for Clinical Decision Making.
Ruben Casanova, Shuhan Xu, Pierre Bost, Sujana Sivapatham, Andrea Jacobs, Reinhard Dummer

Cytometry A· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted.
Lukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, Ramon Staeger, Adhideb Ghosh, Reinhard Dummer

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab.
Dagmar von Bubnoff, Christina Schmitt, Simone M Goldinger, Dirk Schadendorf, Katharina C Kähler, Reinhard Dummer

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Local Skin Reactions Caused by 5-FU 4% Cream for the Treatment of Actinic Keratosis: A Delphi Consensus.
Gabriella Brancaccio, Giulia Briatico, Zoe Apalla, Reinhard Dummer, Jan Eklind

Dermatol Pract Concept· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis